npj Regenerative Medicine, an online journal created by ARMI in partnership with Nature Springer, has reached new heights with an Impact Factor (IF) of 14.404. The journal has also ranked second in the “cell and tissue engineering” category and fifth in the “biomedical engineering” category.
Recently released in the annual Journal Citation Reports by Clarivate Analytics, these metrics build on npj Regenerative Medicine’s debut IF of 7.021, which was announced in 2020 and continue to demonstrate the exceptional quality of research being published and the journal’s influence on the field of regenerative medicine and beyond.
As previously forecasted, the number of articles published in npj Regenerative Medicine has increased since 2020, from 13 articles that year to 54 articles in 2021 and 49 articles thus far in 2022. Overall, the journal has seen a three-fold increase in citations compared to 2019. This also follows an upwards trend observed by Clarivate Analytics among journals in general medicine, critical care, public health, infectious diseases, immunology and basic biomedical sciences in light of the COVID-19 pandemic. This shows the growth of regenerative medicine and stem cell research and its progress towards translation and clinical impact.
Another major factor of npj Regenerative Medicine’s success is its open-access ethos. Here, the journal is capitalising on the well-established benefits of making all content freely available to all researchers worldwide. These benefits include increased citation and usage, greater public engagement, increased collaboration across disciplines and faster impact through the journal’s continual online publication timelines.
This IF reflects the editorial team’s hard work, dedication and expertise in curating a journal that disseminates novel and significant research in the field. Much like the positive feedback loops found in many biological systems, this will continue to enhance the number and quality of submissions to the journal. To this end, npj Regenerative Medicine’s reputation in biomedical research publishing will only strengthen.
Congratulations to the npj Regenerative Medicine team and the Institute on this outstanding achievement!